elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28475676-C2E9D46D-E9E7-4897-A3D9-D44740F984E7
Q28475676-C2E9D46D-E9E7-4897-A3D9-D44740F984E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28475676-C2E9D46D-E9E7-4897-A3D9-D44740F984E7
Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis
P2860
Q28475676-C2E9D46D-E9E7-4897-A3D9-D44740F984E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28475676-C2E9D46D-E9E7-4897-A3D9-D44740F984E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66bca64ae08c27b182a8c4f62694072b3e2fce59
P2860
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance